Pharmanest

Pharmanest

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pharmanest is a US-based, private company offering critical imaging and diagnostic services primarily to the clinical research sector. Founded in 2005 and headquartered in San Diego, it functions as a contract service organization, providing technology-enabled solutions for trial endpoints and patient diagnostics. The company operates in the high-growth intersection of diagnostics and digital health, capitalizing on the increasing complexity and regulatory importance of imaging in modern drug development. Its business model is service-based, generating revenue through partnerships with biotech and pharmaceutical sponsors.

OncologyNeurologyCardiologyMusculoskeletal

Technology Platform

Integrated service platform for clinical trial imaging, encompassing protocol design, secure cloud-based image management (PACS), blinded read portals, and quantitative image analysis workflows compliant with regulatory standards (FDA, EMA).

Opportunities

The growing complexity and regulatory importance of imaging biomarkers in clinical trials, especially in oncology and neurology, drives demand for specialized service providers.
Expansion into AI-powered image analysis and real-world evidence studies presents adjacent growth avenues.

Risk Factors

Revenue dependence on a concentrated biopharma client base and intense competition from larger CROs pose significant risks.
Operational failures in data management or regulatory compliance could damage reputation and lead to financial liabilities.

Competitive Landscape

Competes with large, full-service Contract Research Organizations (CROs) that have internal imaging divisions and with other specialized imaging CROs. Differentiation is based on deep therapeutic area expertise, technology-enabled workflow efficiency, and a strong track record of regulatory compliance.